Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04889027
Other study ID # 2020/017
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 17, 2020
Est. completion date July 1, 2021

Study information

Verified date April 2023
Source Ondokuz Mayis University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to assess Turkish validity and reliability of Standardized Infant Neurodevelopmental Assessment and to spread its use for evaluation in early rehabilitation in our country.


Description:

There are developments in the field of diagnosing children with a high risk of developmental disorders such as cerebral palsy (CP), mental problems and autism spectrum disorder in infancy. In particular, in infants experiencing the onset of extrauterine life in the neonatal intensive care unit, the combination of neonatal neuroimaging along with the assessment of general movements results in a highly accurate prediction of CP . A clinical tool often used in predictions is a neurological examination. Various standard variants are available, such as the Hammersmith Infant Neurological Examination (HINE), Alberta Infant Motor Scale (AIMS). The neurological scale of SINDA is designed as a screening tool as follows: (1) in the first year of life after the neonatal period, that is, in the corrected age range of 6 weeks to 12 months; (2) covers all infant neurological areas; (3) it is standardized, that is, it has a set of items and criteria identical to that age range; (4) results in a score that is largely independent of the baby's age; (5) general pediatricians are easy to use and take about 10 minutes to do (including recording scores); (6) contains a substantial part of items assessing the quality of spontaneous movements; and (7) helps predict developmental outcome .This study aims to assess Turkish validity and reliability of Standardized Infant Neurodevelopmental Assessment and to spread its use for evaluation in early rehabilitation in our country.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date July 1, 2021
Est. primary completion date July 1, 2021
Accepts healthy volunteers No
Gender All
Age group 1 Month to 24 Months
Eligibility Inclusion Criteria: - at-risk infants - discharged from neonatal intensive care unit; - age between 0 - 24 months old (corrected age for premature infants); - having a family acceptance for the participation Exclusion Criteria: - having congenital anomalies, - musculoskeletal disorders, - cyanotic congenital heart disease and - mechanical dependency

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Standardized Infant NeuroDevelopmental Assessment
The neurological scale of SINDA is designed as a screening tool as follows: (1) in the first year of life after the neonatal period, that is, in the corrected age range of 6 weeks to 12 months; (2) covers all infant neurological areas; (3) it is standardized, that is, it has a set of items and criteria identical to that age range; (4) results in a score that is largely independent of the baby's age; (5) general pediatricians are easy to use and take about 10 minutes to do (including recording scores); (6) contains a substantial part of items assessing the quality of spontaneous movements; and (7) helps predict developmental outcome (Hadder-Algra et al., 2018).

Locations

Country Name City State
Turkey Nilay Çömük Balci Samsun Atakum

Sponsors (1)

Lead Sponsor Collaborator
Ondokuz Mayis University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Standardized Infant NeuroDevelopmental Assessment The neurological scale of SINDA is designed as a screening tool as follows: (1) in the first year of life after the neonatal period, that is, in the corrected age range of 6 weeks to 12 months; (2) covers all infant neurological areas; (3) it is standardized, that is, it has a set of items and criteria identical to that age range; (4) results in a score that is largely independent of the baby's age; (5) general pediatricians are easy to use and take about 10 minutes to do (including recording scores); (6) contains a substantial part of items assessing the quality of spontaneous movements; and (7) helps predict developmental outcome 20-30 minutes
Secondary Hammersmith Infant Neurological Examination (HINE) The HINE includes three sections, the Neurological Examination, the Development of Motor Functions and the State of Behaviour. The first section evaluates cranial nerve, posture, movements, tone and reflexes. These items are not age-dependent. The second section evaluates head control, sitting, voluntary grasping, rolling, crawling and walking. The third section evaluates state of consciousness, emotional state and social orientation. 30-40 minutes
Secondary Alberta Infant Motor Scale (AIMS). This scale is a norm-referenced observational tool designed for the evaluation of gross motor development in infants from birth to 18 months of age or the acquisition of independent walking. It consists of 58 items and four subscales: supine (9 items), prone (21 items), sitting (12 items) and standing (16 items), which are observed in postural alignment, antigravity movements and surface contact. 30-45 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05030337 - Optimising Ventilation in Preterms With Closed-loop Oxygen Control N/A
Completed NCT02916914 - Impact of Feeding Interval of Preterms on the Time of Transition From Tube Feeding to Oral Feeding N/A
Not yet recruiting NCT06335524 - Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants N/A
Completed NCT02391389 - VentFirst Pilot: Ventilating Preterm Infants During Delayed Cord Clamping N/A
Completed NCT00419588 - Growth of Airways and Lung Tissues in Premature and Healthy Infants
Completed NCT05217186 - Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Completed NCT04886310 - Peabody Developmental Motor Scale-2 in 0 - 24 Months in Turkey
Enrolling by invitation NCT04478487 - Novel Human Milk Based Human Milk Fortifier N/A
Not yet recruiting NCT05592431 - Effect of Volume Guarantee-High Frequency Oscillatory Ventilation on Cerebral Blood Flow in Neonates N/A
Enrolling by invitation NCT05011071 - The Alberta BLOOM Premature Child Study
Completed NCT04889846 - The Effects of SAFE Early Intervention Approach in Premature Infants in Turkey N/A
Recruiting NCT04064398 - Evaluation of Gastric Residuals and Feedings Progression N/A
Completed NCT04500353 - Routine Or Selective Application of a Face Mask for Preterm Infants at Birth: the ROSA Trial N/A
Completed NCT04247308 - Multi Modal Stimulations in Pre-term Neonates N/A
Completed NCT03860142 - Evolution of Food Orality in Children Aged Between 24 and 36 Months: Comparison of the Severity and Specificities of Disorders Between Two Populations of Children, Born Very Prematurely and Born at Term
Completed NCT04234152 - Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study N/A
Terminated NCT04641000 - The Alberta BLOOM Long Term Follow Up Study
Completed NCT04284891 - Critical Respiratory Diseases in Ex-preterm Infants in PICU
Completed NCT04327466 - Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants N/A
Completed NCT00062452 - Esophageal Motility and Airway Defenses Among Infants N/A